Equels Thomas K's Form 4 filing
AIM ImmunoTech Inc. (AIM) · filed Sep 29, 2023
- Accession no.
- 0001493152-23-034802
- Filed
- Sep 29, 2023, 3:29 PM ET
- Trade date
- Sep 29, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $10.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Equels Thomas KCIK 0001450324 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2023 | Common Stock | PPurchaseAcquired | +22,676 | $0.441 | +$10,000.12 | 606,836 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.